CAS: 27144-18-9; 3-(Tritylthio)Propanoic Acid

该化合物是一种化学化合物,其特点是其独特的结构,包括三丁基化合物和美丙二丙基酸混合物;三丁基化合物,即散装芳香替代成分,增强了该化合物在有机溶剂中的稳定性和溶性;该化合物通常用于有机合成和生物化学,特别是在浸泡物合成过程中保护硫醇组;该化合物具有一种三醇(-SH)功能组,该组具有反应性,能够参与各种化学反应,包括氧化和溶解结合形成;该碳箱酸组的存在有助于其酸性,使其在溶液中作为弱酸发挥作用;S-Trityl-3-captopropiocial酸,由于能够形成稳定的金属离子复合体,该化合物经常用于制药和蛋白相互作用的研究;其特定的再活性和功能组使其成为合成有机化学的一个有价值的中间体.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号76-83-5 三苯基氯甲烷 | CAS号107-96-0 3-巯基丙酸 | CAS号76-84-6 三苯基甲醇 | CAS号590-92-1 3-溴丙酸 | CAS号3695-77-0 三苯甲硫醇 | CAS号76-84-6 三苯基甲醇 | CAS号52574-08-0 3-(乙酰胺甲硫基)丙酸 | CAS号129431-12-5 1-[1-氧代-3-[(三苯基... | CAS号19303-32-3 1-methyl-1,3,3-... | CAS号519-73-3 三苯基甲烷

合成工艺路线路线简述

    3-溴丙酸,三苯甲硫醇置于sodium Hydride体系中,用 N,N-二甲基甲酰胺 用作溶剂,化学反应 1.0H,以82%的收率获得3-(三苯甲硫基)丙酸
    参考文献:人生长抑素受体特异性的骨架环类似物含有新型硫构建单元.
    标题:人生长抑素受体特异性的骨架环类似物含有新型硫构建单元.
    摘要:生长抑素14(somatostatin)及其临床可用的类似物奥曲肽,兰瑞肽和伐普肽是生长激素,胰岛素和胰高血糖素释放的有效抑制剂.最近,描述了一种具有体内内分泌选择性的新型骨干环生长抑素类似物c(gaba-Phe-Trp-(d)trp-Lys-Thr-Phe-Glyc3-Nh(2))(类似物1,Ptr 3173).这种长效八肽对人重组生长抑素受体(hsst)hsst2,Hsst4和hsst5具有高亲和力.其新颖的结合特性可有效抑制体内生长激素,但不能抑制胰岛素释放.我们报告了与1相关的化合物的合成,生物活性和构效关系研究.在这些类似物中,1的内酰胺桥被骨架二硫键取代.我们提出了一种新的方法,通过利用含硫的建筑单元对树脂骨架骨架化肽的构象约束.如在各种酶混合物中测试的,这些1的二硫键主链环状类似物显示出显着的代谢稳定性.受体结合测定揭示了与它们的原型相比,这些类似物的不同的受体选择性特征.发
    Doi:10.1021/jm0100281

    海关参考信息

    专利信息


    专利号:US-8816050-B2
    优先权日:2006-03-22
    标题:Method of preparing glycopeptides
    发明人:WONG CHI-HUEY; BRIK ASHRAF; YANG YU-YING; FICHT SIMON; PAYNE RICHARD
    权利人:WONG CHI-HUEY; BRIK ASHRAF; YANG YU-YING; FICHT SIMON; PAYNE RICHARD; SCRIPPS RESEARCH INST
    摘要:A method is provided for the synthesis of glycopeptides using a sugar assisted ligation strategy, wherein an N-terminal peptide portion in the form of a thioester is coopled with a C-terminal peptide portion bearing a carbohydrate moiety comprising a thiol group.

    专利号:WO-2023179723-A1
    优先权日:2022-03-25
    标题:Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof in preparation of site-directed drug conjugate
    发明人:HUANG WEI; TANG FENG; ZENG YUE
    权利人:SHANGHAI INST MATERIA MEDICA CAS
    摘要:Provided in the present invention are a cleavable fragment directed by an affinity fragment, the design and the synthesis thereof, and the use thereof in the preparation of a site-directed drug conjugate. Specifically, provided in the present invention is a conjugate with a ligand affinity directing group. The conjugate is as represented by formula I: AT-CL-R (I), wherein AT is an affinity moiety for a target protein (TP); CL is a cleavable fragment which has a self-cleaving reactivity; and R is a group to be modified to the target protein.

    专利号:EP-1206494-B1
    优先权日:1999-08-02
    标 题:Computational design methods for making molecular mimetics
    发明人:CASSET FLORENCE; GRANIER CLAUDE; KACZOREK MICHEL; LAHANA ROGER; REES ANTHONY; ROUX FLORENCE
    权利人:SYNT EM SA
    摘要:Methods are proposed for the design and synthesis of a molecule which mimics the activity of a parent molecule. In particular the methods relate to computationally identifying chemical groups of a parent molecule for inclusion in a mimetic, designing a mimetic taking into account the folding structure of the parent, designing a mimetic using a relative geometrical relationship of chemical groups in the parent molecule, designing a mimetic using a molecular dynamics simulation of the mimetic, and screening potential mimetics using molecular dynamics simulation.

    专利号:US-8349899-B1
    优先权日:2008-12-03
    标题:Selective inhibitors of EG5 motors and methods of use
    发明人:ARTERBURN JEFFREY; SHUSTER CHARLES
    权利人:ARROWHEAD CT INC; ARTERBURN JEFFREY; SHUSTER CHARLES
    摘要:Embodiments of the present invention comprises a compound of formula I or its enantiomer, diastereomer, stereoisomer or its pharmaceutically acceptable salt, methods of use and methods of synthesis.

    专利号:US-9073978-B2
    优先权日:2011-03-10
    标 题:Method for producing glycopeptide having sialyl sugar chain, sialyl sugar chain-added amino acid derivative to be used in same, and glycopeptide
    发明人:KAJIHARA YASUHIRO; MURAKAMI MASUMI; ISHII KAZUYUKI
    权利人:KAJIHARA YASUHIRO; MURAKAMI MASUMI; ISHII KAZUYUKI; GLYTECH INC
    摘要:[Technical Problem] n To provide a method for manufacturing that enables to obtain a targeted glycopeptide harboring a sialyl sugar chain in high yield without decomposing sialic acid at a non-reducing terminal of sugar chain when the glycopeptide is synthesized by a Boc solid phase synthesis method. n [Solution to Problem] n The present invention is characterized in that the Boc-sialylglycosylated amino acid derivative used in Boc solid phase synthesis method is one where the carboxyl group of the sialic acid at the sugar chain non-reducing terminal is protected with a phenacyl group.

    专利号:CN-107903389-B
    优先权日:2017-12-19
    标题:Synthesis and application of E-selectin-targeted polyethylene glycol two-end double-modified antitumor drug
    天津科创医药中间体技术生产力促进有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.scipharmacn.com
    企业联系电话:022-60116533👤
    📞天津科创医药中间体技术生产力促进有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:022-60116533
    手机:13207668525
    传真:022-60979672
    邮箱:saleskc@scipharmacn.com
    通信地址: 天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
    邮编: 300118
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Scott H Medina, Et Al. Cancer Cell Surface Induced Peptide Folding Allows Intracellular Translocation Of Drug. J Control Release. 2015 Jul 10:209:317-26.

    合成参考文献


    参考文献:10.1007/978-1-0716-0720-6_7
    摘要:Pulido D, Royo M. Synthesis of Peptide-Oligoethylene Glycol (OEG) Conjugates for Multivalent Modification of Nanomaterials. 2020. In: Springer Protocols Handbooks.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知